|
 | 鹏华创新升级A(012093)基金投资组合(持股) 年份： | | 截止日期 | 股票代码 | 股票名称 | 数量(万股) | 持有市值(万元) | 占基金资产净值比例(%) | | 2024-12-31 | 688428 | 诺诚健华-U | 353.63 | 4342.53 | 9.24% | | 2024-12-31 | 688235 | 百济神州-U | 26.89 | 4330.23 | 9.21% | | 2024-12-31 | 688192 | 迪哲医药-U | 81.81 | 3392.78 | 7.22% | | 2024-12-31 | 688197 | 首药控股-U | 107.44 | 3206.02 | 6.82% | | 2024-12-31 | 688266 | 泽璟制药-U | 48.06 | 2994.34 | 6.37% | | 2024-12-31 | 688506 | 百利天恒-U | 14.38 | 2757.35 | 5.87% | | 2024-12-31 | 688331 | 荣昌生物 | 81.25 | 2446.47 | 5.21% | | 2024-12-31 | 688302 | 海创药业-U | 62.06 | 1905.99 | 4.06% | | 2024-12-31 | 600707 | 彩虹股份 | 196.08 | 1611.78 | 3.43% | | 2024-12-31 | 002755 | 奥赛康 | 121.51 | 1544.35 | 3.29% | |
|